Fiscal Note
SB0197S01 - Preferred Drug List Revisions
State Impact:
Enactment of this legislation may result in savings of up to $460,600 General Fund and $1,124,400 Federal Funds in FY 2009 ($1,585,000 total). In FY 2010 savings may be as high as $921,200 General Fund and $2,248,800 Federal Funds ($3,170,000 total).
| Funding Source | FY 2008 Approp. | FY 2009 Approp. | FY 2010 Approp. | FY 2008 Revenue | FY 2009 Revenue | FY 2010 Revenue |
| General Fund | $0 | ($921,200) | ($921,200) | $0 | $0 | $0 |
| General Fund, One-Time | $0 | $460,600 | $0 | $0 | $0 | $0 |
| Federal Funds | $0 | ($1,124,400) | ($2,248,800) | $0 | $0 | $0 |
| Total | $0 | ($1,585,000) | ($3,170,000) | $0 | $0 | $0 |
Individual, Business and/or Local Impact:
Enactment of this bill likely will not result in direct, measurable costs and/or benefits for individuals, businesses, or local governments.
| 2/29/2008, 11:33:38 AM, Lead Analyst: Frandsen, R. | Office of the Legislative Fiscal Analyst |